CRISPR activation of the ribosome-associated quality control factor ASCC3 ameliorates fragile X syndrome phenotypes in mice

Journal:

Science Translational Medicine

Published:

2025-10-08

DOI:

10.1126/scitranslmed.adq3551

Affiliations:

8

Authors:

12

Go to article

Institutions	Authors	Share
Stanford University School of Medicine, United States of America (USA)	6.333333	0.53
Mayo Clinic's Campus in Florida, United States of America (USA)	2.000000	0.17
Stanford University, United States of America (USA)	1.333333	0.11
Washington University in St. Louis (WUSTL), United States of America (USA)	1.000000	0.08
National Institute of Genetics (NIG), ROIS, Japan	1.000000	0.08
Chan Zuckerberg Biohub (CZ Biohub), United States of America (USA)	0.333333	0.03

Interested in Clinical Sciences?